This report aims to provide a comprehensive presentation of the global market for Hepatic Encephalopathy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatic Encephalopathy Drug. This report contains market size and forecasts of Hepatic Encephalopathy Drug in global, including the following market information:
Global Hepatic Encephalopathy Drug Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Hepatic Encephalopathy Drug Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five Hepatic Encephalopathy Drug companies in 2022 (%)
The global Hepatic Encephalopathy Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
RBX-2660 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatic Encephalopathy Drug include Alfa Wassermann S.p.A, Cosmo Pharmaceuticals S.p.A, Horizon Pharma Plc, KannaLife Sciences, Inc., Ocera Therapeutics, Inc., Rebiotix Inc., Spherium Biomed S.L. and Umecrine Cognition AB, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatic Encephalopathy Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatic Encephalopathy Drug Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Hepatic Encephalopathy Drug Market Segment Percentages, by Type, 2022 (%)
RBX-2660
KLS-13019
GR-3027
SYNB-1020
Others
Global Hepatic Encephalopathy Drug Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Hepatic Encephalopathy Drug Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global Hepatic Encephalopathy Drug Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Hepatic Encephalopathy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatic Encephalopathy Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatic Encephalopathy Drug revenues share in global market, 2022 (%)
Key companies Hepatic Encephalopathy Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Hepatic Encephalopathy Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alfa Wassermann S.p.A
Cosmo Pharmaceuticals S.p.A
Horizon Pharma Plc
KannaLife Sciences, Inc.
Ocera Therapeutics, Inc.
Rebiotix Inc.
Spherium Biomed S.L.
Umecrine Cognition AB
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatic Encephalopathy Drug, market overview.
Chapter 2: Global Hepatic Encephalopathy Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatic Encephalopathy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatic Encephalopathy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatic Encephalopathy Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatic Encephalopathy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatic Encephalopathy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatic Encephalopathy Drug Overall Market Size
2.1 Global Hepatic Encephalopathy Drug Market Size: 2022 VS 2030
2.2 Global Hepatic Encephalopathy Drug Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Hepatic Encephalopathy Drug Sales: 2018-2030
3 Company Landscape
3.1 Top Hepatic Encephalopathy Drug Players in Global Market
3.2 Top Global Hepatic Encephalopathy Drug Companies Ranked by Revenue
3.3 Global Hepatic Encephalopathy Drug Revenue by Companies
3.4 Global Hepatic Encephalopathy Drug Sales by Companies
3.5 Global Hepatic Encephalopathy Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatic Encephalopathy Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatic Encephalopathy Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatic Encephalopathy Drug Players in Global Market
3.8.1 List of Global Tier 1 Hepatic Encephalopathy Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatic Encephalopathy Drug Market Size Markets, 2022 & 2030
4.1.2 RBX-2660
4.1.3 KLS-13019
4.1.4 GR-3027
4.1.5 SYNB-1020
4.1.6 Others
4.2 By Type - Global Hepatic Encephalopathy Drug Revenue & Forecasts
4.2.1 By Type - Global Hepatic Encephalopathy Drug Revenue, 2018-2023
4.2.2 By Type - Global Hepatic Encephalopathy Drug Revenue, 2024-2030
4.2.3 By Type - Global Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
4.3 By Type - Global Hepatic Encephalopathy Drug Sales & Forecasts
4.3.1 By Type - Global Hepatic Encephalopathy Drug Sales, 2018-2023
4.3.2 By Type - Global Hepatic Encephalopathy Drug Sales, 2024-2030
4.3.3 By Type - Global Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
4.4 By Type - Global Hepatic Encephalopathy Drug Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatic Encephalopathy Drug Market Size, 2022 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Hepatic Encephalopathy Drug Revenue & Forecasts
5.2.1 By Application - Global Hepatic Encephalopathy Drug Revenue, 2018-2023
5.2.2 By Application - Global Hepatic Encephalopathy Drug Revenue, 2024-2030
5.2.3 By Application - Global Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
5.3 By Application - Global Hepatic Encephalopathy Drug Sales & Forecasts
5.3.1 By Application - Global Hepatic Encephalopathy Drug Sales, 2018-2023
5.3.2 By Application - Global Hepatic Encephalopathy Drug Sales, 2024-2030
5.3.3 By Application - Global Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
5.4 By Application - Global Hepatic Encephalopathy Drug Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Hepatic Encephalopathy Drug Market Size, 2022 & 2030
6.2 By Region - Global Hepatic Encephalopathy Drug Revenue & Forecasts
6.2.1 By Region - Global Hepatic Encephalopathy Drug Revenue, 2018-2023
6.2.2 By Region - Global Hepatic Encephalopathy Drug Revenue, 2024-2030
6.2.3 By Region - Global Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
6.3 By Region - Global Hepatic Encephalopathy Drug Sales & Forecasts
6.3.1 By Region - Global Hepatic Encephalopathy Drug Sales, 2018-2023
6.3.2 By Region - Global Hepatic Encephalopathy Drug Sales, 2024-2030
6.3.3 By Region - Global Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Hepatic Encephalopathy Drug Revenue, 2018-2030
6.4.2 By Country - North America Hepatic Encephalopathy Drug Sales, 2018-2030
6.4.3 US Hepatic Encephalopathy Drug Market Size, 2018-2030
6.4.4 Canada Hepatic Encephalopathy Drug Market Size, 2018-2030
6.4.5 Mexico Hepatic Encephalopathy Drug Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Hepatic Encephalopathy Drug Revenue, 2018-2030
6.5.2 By Country - Europe Hepatic Encephalopathy Drug Sales, 2018-2030
6.5.3 Germany Hepatic Encephalopathy Drug Market Size, 2018-2030
6.5.4 France Hepatic Encephalopathy Drug Market Size, 2018-2030
6.5.5 U.K. Hepatic Encephalopathy Drug Market Size, 2018-2030
6.5.6 Italy Hepatic Encephalopathy Drug Market Size, 2018-2030
6.5.7 Russia Hepatic Encephalopathy Drug Market Size, 2018-2030
6.5.8 Nordic Countries Hepatic Encephalopathy Drug Market Size, 2018-2030
6.5.9 Benelux Hepatic Encephalopathy Drug Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Hepatic Encephalopathy Drug Revenue, 2018-2030
6.6.2 By Region - Asia Hepatic Encephalopathy Drug Sales, 2018-2030
6.6.3 China Hepatic Encephalopathy Drug Market Size, 2018-2030
6.6.4 Japan Hepatic Encephalopathy Drug Market Size, 2018-2030
6.6.5 South Korea Hepatic Encephalopathy Drug Market Size, 2018-2030
6.6.6 Southeast Asia Hepatic Encephalopathy Drug Market Size, 2018-2030
6.6.7 India Hepatic Encephalopathy Drug Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Hepatic Encephalopathy Drug Revenue, 2018-2030
6.7.2 By Country - South America Hepatic Encephalopathy Drug Sales, 2018-2030
6.7.3 Brazil Hepatic Encephalopathy Drug Market Size, 2018-2030
6.7.4 Argentina Hepatic Encephalopathy Drug Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales, 2018-2030
6.8.3 Turkey Hepatic Encephalopathy Drug Market Size, 2018-2030
6.8.4 Israel Hepatic Encephalopathy Drug Market Size, 2018-2030
6.8.5 Saudi Arabia Hepatic Encephalopathy Drug Market Size, 2018-2030
6.8.6 UAE Hepatic Encephalopathy Drug Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Alfa Wassermann S.p.A
7.1.1 Alfa Wassermann S.p.A Company Summary
7.1.2 Alfa Wassermann S.p.A Business Overview
7.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Major Product Offerings
7.1.4 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.1.5 Alfa Wassermann S.p.A Key News & Latest Developments
7.2 Cosmo Pharmaceuticals S.p.A
7.2.1 Cosmo Pharmaceuticals S.p.A Company Summary
7.2.2 Cosmo Pharmaceuticals S.p.A Business Overview
7.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Major Product Offerings
7.2.4 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.2.5 Cosmo Pharmaceuticals S.p.A Key News & Latest Developments
7.3 Horizon Pharma Plc
7.3.1 Horizon Pharma Plc Company Summary
7.3.2 Horizon Pharma Plc Business Overview
7.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Major Product Offerings
7.3.4 Horizon Pharma Plc Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.3.5 Horizon Pharma Plc Key News & Latest Developments
7.4 KannaLife Sciences, Inc.
7.4.1 KannaLife Sciences, Inc. Company Summary
7.4.2 KannaLife Sciences, Inc. Business Overview
7.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Major Product Offerings
7.4.4 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.4.5 KannaLife Sciences, Inc. Key News & Latest Developments
7.5 Ocera Therapeutics, Inc.
7.5.1 Ocera Therapeutics, Inc. Company Summary
7.5.2 Ocera Therapeutics, Inc. Business Overview
7.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Major Product Offerings
7.5.4 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.5.5 Ocera Therapeutics, Inc. Key News & Latest Developments
7.6 Rebiotix Inc.
7.6.1 Rebiotix Inc. Company Summary
7.6.2 Rebiotix Inc. Business Overview
7.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Major Product Offerings
7.6.4 Rebiotix Inc. Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.6.5 Rebiotix Inc. Key News & Latest Developments
7.7 Spherium Biomed S.L.
7.7.1 Spherium Biomed S.L. Company Summary
7.7.2 Spherium Biomed S.L. Business Overview
7.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Major Product Offerings
7.7.4 Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.7.5 Spherium Biomed S.L. Key News & Latest Developments
7.8 Umecrine Cognition AB
7.8.1 Umecrine Cognition AB Company Summary
7.8.2 Umecrine Cognition AB Business Overview
7.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Major Product Offerings
7.8.4 Umecrine Cognition AB Hepatic Encephalopathy Drug Sales and Revenue in Global (2018-2023)
7.8.5 Umecrine Cognition AB Key News & Latest Developments
8 Global Hepatic Encephalopathy Drug Production Capacity, Analysis
8.1 Global Hepatic Encephalopathy Drug Production Capacity, 2018-2030
8.2 Hepatic Encephalopathy Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatic Encephalopathy Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatic Encephalopathy Drug Supply Chain Analysis
10.1 Hepatic Encephalopathy Drug Industry Value Chain
10.2 Hepatic Encephalopathy Drug Upstream Market
10.3 Hepatic Encephalopathy Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatic Encephalopathy Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hepatic Encephalopathy Drug in Global Market
Table 2. Top Hepatic Encephalopathy Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatic Encephalopathy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatic Encephalopathy Drug Revenue Share by Companies, 2018-2023
Table 5. Global Hepatic Encephalopathy Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Hepatic Encephalopathy Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatic Encephalopathy Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Hepatic Encephalopathy Drug Product Type
Table 9. List of Global Tier 1 Hepatic Encephalopathy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatic Encephalopathy Drug Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Hepatic Encephalopathy Drug Sales (K Pcs), 2024-2030
Table 26. By Country - North America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Hepatic Encephalopathy Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Hepatic Encephalopathy Drug Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Hepatic Encephalopathy Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Hepatic Encephalopathy Drug Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Hepatic Encephalopathy Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Hepatic Encephalopathy Drug Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Hepatic Encephalopathy Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Hepatic Encephalopathy Drug Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales, (K Pcs), 2024-2030
Table 46. Alfa Wassermann S.p.A Company Summary
Table 47. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product Offerings
Table 48. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Alfa Wassermann S.p.A Key News & Latest Developments
Table 50. Cosmo Pharmaceuticals S.p.A Company Summary
Table 51. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product Offerings
Table 52. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Cosmo Pharmaceuticals S.p.A Key News & Latest Developments
Table 54. Horizon Pharma Plc Company Summary
Table 55. Horizon Pharma Plc Hepatic Encephalopathy Drug Product Offerings
Table 56. Horizon Pharma Plc Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Horizon Pharma Plc Key News & Latest Developments
Table 58. KannaLife Sciences, Inc. Company Summary
Table 59. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product Offerings
Table 60. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. KannaLife Sciences, Inc. Key News & Latest Developments
Table 62. Ocera Therapeutics, Inc. Company Summary
Table 63. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product Offerings
Table 64. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Ocera Therapeutics, Inc. Key News & Latest Developments
Table 66. Rebiotix Inc. Company Summary
Table 67. Rebiotix Inc. Hepatic Encephalopathy Drug Product Offerings
Table 68. Rebiotix Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Rebiotix Inc. Key News & Latest Developments
Table 70. Spherium Biomed S.L. Company Summary
Table 71. Spherium Biomed S.L. Hepatic Encephalopathy Drug Product Offerings
Table 72. Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Spherium Biomed S.L. Key News & Latest Developments
Table 74. Umecrine Cognition AB Company Summary
Table 75. Umecrine Cognition AB Hepatic Encephalopathy Drug Product Offerings
Table 76. Umecrine Cognition AB Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Umecrine Cognition AB Key News & Latest Developments
Table 78. Hepatic Encephalopathy Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 79. Global Hepatic Encephalopathy Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Hepatic Encephalopathy Drug Production by Region, 2018-2023 (K Pcs)
Table 81. Global Hepatic Encephalopathy Drug Production by Region, 2024-2030 (K Pcs)
Table 82. Hepatic Encephalopathy Drug Market Opportunities & Trends in Global Market
Table 83. Hepatic Encephalopathy Drug Market Drivers in Global Market
Table 84. Hepatic Encephalopathy Drug Market Restraints in Global Market
Table 85. Hepatic Encephalopathy Drug Raw Materials
Table 86. Hepatic Encephalopathy Drug Raw Materials Suppliers in Global Market
Table 87. Typical Hepatic Encephalopathy Drug Downstream
Table 88. Hepatic Encephalopathy Drug Downstream Clients in Global Market
Table 89. Hepatic Encephalopathy Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatic Encephalopathy Drug Segment by Type in 2022
Figure 2. Hepatic Encephalopathy Drug Segment by Application in 2022
Figure 3. Global Hepatic Encephalopathy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatic Encephalopathy Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hepatic Encephalopathy Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. Hepatic Encephalopathy Drug Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Hepatic Encephalopathy Drug Revenue in 2022
Figure 9. By Type - Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 11. By Type - Global Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 12. By Type - Global Hepatic Encephalopathy Drug Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 15. By Application - Global Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 16. By Application - Global Hepatic Encephalopathy Drug Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Hepatic Encephalopathy Drug Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 20. By Region - Global Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 21. By Country - North America Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 22. By Country - North America Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 23. US Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 28. Germany Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 29. France Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 37. China Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 41. India Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 43. By Country - South America Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 44. Brazil Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Hepatic Encephalopathy Drug Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Hepatic Encephalopathy Drug Sales Market Share, 2018-2030
Figure 48. Turkey Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Hepatic Encephalopathy Drug Revenue, (US$, Mn), 2018-2030
Figure 52. Global Hepatic Encephalopathy Drug Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Hepatic Encephalopathy Drug by Region, 2022 VS 2030
Figure 54. Hepatic Encephalopathy Drug Industry Value Chain
Figure 55. Marketing Channels
